Jim Simons's position in G1 Therapeutics is currently worth $2.82 Million. That's 0.00% of their equity portfolio (1692nd largest holding). The investor owns 1.46% of the outstanding G1 Therapeutics stock. The first G1 Therapeutics trade was made in Q1 2018. Since then Jim Simons bought shares seven more times and sold shares on seven occasions. The investor's estimated purchase price is $3.79 Million, resulting in a loss of 26%.